340B Program

In-depth reporting on 340b program, from market shifts and clinical breakthroughs to the essential updates shaping the sector.

A map of the United States of America with a large pill on top of it with a price tag that reads $$$
Pharma

Why drugmakers and hospitals are fighting over the 340B program

At the center is a proposal to shift how drugs are paid for.

Maia Anderson
A map of the United States of America with a large pill on top of it with a price tag that reads $$$
Pharma

Federal report suggests rising drug costs, M&A increase 340B spending

Program drug spending grew from $6.6 billion in 2010 to $43.9 billion in 2021.

Caroline Catherman
Percentage with arrows pointing down crack
Pharma

PhRMA report finds 340B program lost states $6.5b in rebates last year

Welcome to the latest installment in Big Pharma vs. Big Hospital.

Caroline Catherman
orange pill bottles
Pharma

The future of the 340B drug pricing program

The federal program faces several challenges in the near future.

Maia Anderson
Pills and Painkillers on a Grid
Pharma

What is 340B?

The program requires drugmakers to sell discounted drugs to hospitals and clinics.

Maia Anderson

Navigate the healthcare industry

Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.

By subscribing, you accept our Terms & Privacy Policy.

A mobile phone scrolling a newsletter issue of Healthcare Brew